Riggs Asset Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-650
Closed -$13.5K 423
2023
Q3
$13.5K Hold
650
﹤0.01% 221
2023
Q2
$15.6K Hold
650
0.01% 207
2023
Q1
$12.2K Hold
650
﹤0.01% 212
2022
Q4
$10.3K Hold
650
﹤0.01% 208
2022
Q3
$11K Hold
650
﹤0.01% 210
2022
Q2
$9K Hold
650
﹤0.01% 206
2022
Q1
$16K Hold
650
﹤0.01% 209
2021
Q4
$15K Hold
650
﹤0.01% 223
2021
Q3
$11K Hold
650
﹤0.01% 220
2021
Q2
$16K Hold
650
﹤0.01% 214
2021
Q1
$17K Hold
650
0.01% 193
2020
Q4
$35K Sell
650
-16,820
-96% -$906K 0.01% 144
2020
Q3
$2.03M Buy
17,470
+16,820
+2,588% +$1.95M 0.85% 35
2020
Q2
$31K Hold
650
0.01% 118
2020
Q1
$27K Hold
650
0.02% 121
2019
Q4
$28K Hold
650
0.01% 159
2019
Q3
$23K Hold
650
0.01% 153
2019
Q2
$17K Hold
650
0.01% 160
2019
Q1
$17K Hold
650
0.01% 158
2018
Q4
$11K Hold
650
0.01% 154
2018
Q3
$13K Hold
650
0.01% 162
2018
Q2
$10K Hold
650
﹤0.01% 178
2018
Q1
$15K Hold
650
0.01% 180
2017
Q4
$20K Hold
650
0.01% 166
2017
Q3
$24K Hold
650
0.01% 161
2017
Q2
$18K Hold
650
0.01% 192
2017
Q1
$22K Hold
650
0.01% 159
2016
Q4
$19K Sell
650
-650
-50% -$19K 0.01% 158
2016
Q3
$41K Hold
1,300
0.02% 119
2016
Q2
$42K Hold
1,300
0.02% 123
2016
Q1
$36K Hold
1,300
0.03% 118
2015
Q4
$46K Hold
1,300
0.02% 109
2015
Q3
$43K Hold
1,300
0.03% 99
2015
Q2
$54K Hold
1,300
0.03% 101
2015
Q1
$42K Hold
1,300
0.02% 119
2014
Q4
$41K Hold
1,300
0.02% 122
2014
Q3
$32K Buy
+1,300
New +$32K 0.02% 131